Home  /  Resource Library  /  Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony‐stimulating factors in older patients with non‐Hodgkin lymphoma

Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony‐stimulating factors in older patients with non‐Hodgkin lymphoma

Study examined the association between the use of filgrastim and pegfilgrastim and the risk of primary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).